<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE253nnn/GSE253138/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species> Mus musculus</species><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253138</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>A dual role for PSIP1/LEDGF in T-cell acute lymphoblastic leukemia [RNA-seq]</name><description>T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy. Although intensified therapeutic protocols have improved the outcome of T-ALL patients, they coincide with severe short- and long-term side effects. In addition, no salvage therapeutic strategies are available for primary therapy-resistant or relapsed T-ALL, resulting in a dismal outcome for these patients. It highlights the need to identify new targets in T-ALL biology that allow the development of less toxic targeted therapies. PSIP1, a histone mark reader, is a dependency factor in KMT2A-rearranged myeloid leukemia, but is dispensable for normal hematopoiesis, making it an attractive therapeutic target. Nonetheless, rare recurrent inactivating mutations and deletions of PSIP1, suggest that PSIP1 could act as a tumor suppressor in T-ALL. Here, we demonstrate that the loss of Psip1 accelerates T-ALL initiation in mice and we identified a correlation with reduced H3K27me3 binding. Contrastingly, loss of PSIP1 impaired cell proliferation in several human and murine T-ALL cell lines. In these cell lines, PSIP1 loss leads to a significant downregulation of COX20, an assembly factor of the cytochrome c oxidase in the mitochondria, and is associated with a reduction in mitochondrial respiration. Similarly to what was observed for PSIP1, loss of COX20 expression also leads to an impairment of proliferation in these T-ALL cell lines. These data corroborate that PSIP1 can exert a dual role in the context of T-ALL, either as a tumor suppressor gene during tumor initiation or as a dependency factor in tumor maintenance.</description><dates><publication>2024/10/20</publication></dates><accession>GSE253138</accession><cross_references><GSM>GSM8014797</GSM><GSM>GSM8014830</GSM><GSM>GSM8014796</GSM><GSM>GSM8014799</GSM><GSM>GSM8014810</GSM><GSM>GSM8014832</GSM><GSM>GSM8014831</GSM><GSM>GSM8014798</GSM><GSM>GSM8014834</GSM><GSM>GSM8014812</GSM><GSM>GSM8014833</GSM><GSM>GSM8014811</GSM><GSM>GSM8014814</GSM><GSM>GSM8014813</GSM><GSM>GSM8014793</GSM><GSM>GSM8014795</GSM><GSM>GSM8014794</GSM><GSM>GSM8014805</GSM><GSM>GSM8014827</GSM><GSM>GSM8014826</GSM><GSM>GSM8014804</GSM><GSM>GSM8014829</GSM><GSM>GSM8014807</GSM><GSM>GSM8014806</GSM><GSM>GSM8014828</GSM><GSM>GSM8014809</GSM><GSM>GSM8014808</GSM><GSM>GSM8014821</GSM><GSM>GSM8014820</GSM><GSM>GSM8014823</GSM><GSM>GSM8014801</GSM><GSM>GSM8014800</GSM><GSM>GSM8014822</GSM><GSM>GSM8014803</GSM><GSM>GSM8014825</GSM><GSM>GSM8014802</GSM><GSM>GSM8014824</GSM><GSM>GSM8014816</GSM><GSM>GSM8014815</GSM><GSM>GSM8014818</GSM><GSM>GSM8014817</GSM><GSM>GSM8014819</GSM><GPL>18573</GPL><GPL>19057</GPL><GSE>253138</GSE><taxon> Mus musculus</taxon><taxon>Homo sapiens</taxon><PMID>[39485844]</PMID></cross_references></HashMap>